
Rebipla L 75mg/20mg Capsule SR
Marketer
Lacip Healthcare
Salt Composition
Levosulpiride (75mg) + Rabeprazole (20mg)
Overview Rebipla L 75mg/20mg Capsule SR
Gastro-esophageal reflux disease (GERD), peptic ulcers, and irritable bowel syndrome may be treated with the prescription medication, Rebipla L 75mg/20mg Sustained-Release Capsules. This medication lowers excessive stomach acid production and prevents its backflow into the esophagus. Dosage and duration should follow your physician's instructions; this may vary depending on your condition and response. Complete the prescribed course; premature cessation could lead to symptom recurrence and disease exacerbation. Inform your healthcare provider of all other medications you are using, as interactions are possible. Common side effects, often transient, include nausea, abdominal discomfort, diarrhea, gas, constipation, headache, fatigue, and flu-like symptoms. Report any concerning side effects immediately. Dizziness and drowsiness are potential side effects; avoid driving or mentally demanding tasks until their impact is known. Alcohol consumption should be avoided due to increased drowsiness risk. Lifestyle adjustments, such as a high-fiber diet, avoidance of trigger foods, increased hydration, and regular physical activity, can enhance treatment outcomes. Prior to commencing treatment, disclose any kidney or liver conditions, and inform your doctor of pregnancy, pregnancy plans, or breastfeeding.
Uses of Rebipla L 75mg/20mg Capsule SR
Managing gastroesophageal reflux disease (GERD) | Treating peptic ulcers | Addressing irritable bowel syndrome
Major Benefits of Rebipla L 75mg/20mg Capsule SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Rebipla L 75mg/20mg SR capsule whole; do not chew, crush, or fracture it. Administer this medication on an empty stomach.
Common Side effects of Rebipla L 75mg/20mg Capsule SR:
- Nausea
- Stomach pain
- Diarrhea
- Flatulence
- Constipation
- Headache
- Dizziness
- Weakness
- Sleepiness
- Flu-like symptoms
How to use Rebipla L 75mg/20mg Capsule SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Rebipla L 75mg/20mg SR Capsule whole; do not alter its form by chewing, crushing, or breaking. Administer on an empty stomach.
How Rebipla L 75mg/20mg Capsule SR works:
Levosulpiride and rabeprazole, at doses of 75mg and 20mg respectively, are combined in the extended-release Rebipla L capsule.
SAFETY ADVICE
AlcoholUNSAFE
Combining Rebipla L 75mg/20mg SR capsules with alcohol is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Rebipla L 75mg/20mg SR Capsules during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible hazards prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Data on Rebipla L 75mg/20mg SR capsule use while breastfeeding is currently lacking. Seek medical advice from your physician.
DrivingUNSAFE
Driving ability may be impaired by side effects associated with taking Rebipla L 75mg/20mg sustained-release capsules.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding Rebipla L 75mg/20mg SR capsule use in individuals with kidney impairment. Medical advice is recommended. Nevertheless, preliminary findings indicate a need for prudence when prescribing this medication to such patients.
LiverCAUTION
Individuals with severe hepatic impairment should exercise caution when using Rebipla L 75mg/20mg sustained-release capsules. Dosage modification of Rebipla L 75mg/20mg sustained-release capsules may be necessary. Physician consultation is advised.
What if you forget to take Rebipla L 75mg/20mg Capsule SR :
Should you forget a Rebipla L 75mg/20mg SR Capsule dose, administer it promptly. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Rebipla L 75mg/20mg Capsule SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Gastrointestinal system |
